You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CD82 (CD82) Antibodies

Full name:
anti-CD82 Molecule Antibodies (CD82)
On are 142 CD82 Molecule (CD82) Antibodies from 22 different suppliers available. Additionally we are shipping CD82 Proteins (7) and CD82 Kits (3) and many more products for this protein. A total of 162 CD82 products are currently listed.
4F9, AA682076, AL023070, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27
list all antibodies Gene Name GeneID UniProt
CD82 12521 P40237
CD82 3732 P27701
CD82 83628  

Show all species

Show all synonyms

Most Popular Reactivities for anti-CD82 (CD82) Antibodies

Select your species and application

anti-Mouse (Murine) CD82 Antibodies:

anti-Human CD82 Antibodies:

anti-Rat (Rattus) CD82 Antibodies:

All available anti-CD82 Antibodies

Go to our pre-filtered search.

Top referenced anti-CD82 Antibodies

  1. Human Monoclonal CD82 Primary Antibody for Func, ICC - ABIN1043024 : Ueda, Ichikawa, Tamaru, Mikata, Akakura, Akimoto, Imai, Yoshie, Shiraishi, Yatani, Ito, Shimazaki: Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. in The American journal of pathology 1996 (PubMed)
    Show all 6 references for ABIN1043024

  2. Human Monoclonal CD82 Primary Antibody for Func, FACS - ABIN1106584 : Fukudome, Furuse, Imai, Nishimura, Takagi, Hinuma, Yoshie et al.: Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen ... in Journal of virology 1992 (PubMed)
    Show all 5 references for ABIN1106584

  3. Human Polyclonal CD82 Primary Antibody for EIA, IHC (p) - ABIN500108 : Dong, Lamb, Rinker-Schaeffer, Vukanovic, Ichikawa, Isaacs, Barrett: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. in Science (New York, N.Y.) 1995 (PubMed)
    Show all 4 references for ABIN500108

  4. Human Monoclonal CD82 Primary Antibody for FACS, IHC - ABIN1383874 : Zhou, Liu, Reddivari, Zhang: The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. in Cancer research 2004 (PubMed)
    Show all 2 references for ABIN1383874

  5. Human Monoclonal CD82 Primary Antibody for FACS - ABIN1383875 : Tohami, Drucker, Shapiro, Radnay, Lishner: Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007 (PubMed)
    Show all 2 references for ABIN1383875

  6. Human Polyclonal CD82 Primary Antibody for EIA, IHC (p) - ABIN358740 : Zhang, Lane, Charrin, Rubinstein, Liu: EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. in Cancer research 2003 (PubMed)
    Show all 2 references for ABIN358740

  7. Virus Monoclonal CD82 Primary Antibody for FACS - ABIN1106589 : Schoenfeld, Bauer, Grimm: The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004 (PubMed)
    Show all 2 references for ABIN1106589

  8. Human Monoclonal CD82 Primary Antibody for IHC (fro), FACS - ABIN1106586 : Gellersen, Briese, Oberndörfer, Redlin, Samalecos, Richter, Löning, Schulte, Bamberger: Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications. in The American journal of pathology 2007 (PubMed)
    Show all 2 references for ABIN1106586

More Antibodies against CD82 Interaction Partners

Mouse (Murine) CD82 Molecule (CD82) interaction partners

  1. The perturbation of CD82-ganglioside-CD44 (show CD44 Antibodies) signaling attenuates pathological angiogenesis.

  2. Loss of Kai1 expression is associated with neoplasm metastasis.

  3. The synergistic effects of CD82 and GM3 (show GRM6 Antibodies) or GM2 (show CYB5D2 Antibodies)/GM3 (show GRM6 Antibodies) ganglioside on EGFR (show EGFR Antibodies) expression and phosphorylation and cMet activation are responsible for CD82 inhibition of EGF (show EGF Antibodies)- and HGF (show HGF Antibodies)-dependent cell motility and migration of Hepa1-6 cells.

  4. CD81 (show CD81 Antibodies) promotes the microvillus formation and/or extension while tetraspanin CD82 inhibits these events. In addition, CD81 (show CD81 Antibodies) enhances the outward bending of the plasma membrane while CD82 inhibits it.

  5. the CD82 tetraspanin is specifically recruited to pathogen-containing phagosomes prior to fusion with lysosomes.

  6. KAI1 has a role in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase

  7. Hypoxia-dependent induction of KAI1 was directly mediated by hypoxia-inducible factor-1alpha binding on the promoter, which subsequently caused increased recruitment of RNA polymerase II for transcriptional activation.

  8. An antibody to this protein that can specifically detect murine Kai1/CD82, should be useful in addressing the mechanism of action of Kai1 in metastatic suppression.

  9. gp78 (show AMFR Antibodies) promotes sarcoma metastasis by targeting KAI1 for degradation

  10. The transgenic adenocarcinoma of mouse prostate model encompasses androgen depletion independent sublines with increased tumorigenicity and invasiveness. All showed downregulation in tumor suppressor, E-cadherin (show CDH1 Antibodies), and metastatis suppressor, KAI-1.

Human CD82 Molecule (CD82) interaction partners

  1. Survivin (show BIRC5 Antibodies), Bcl-2 (show BCL2 Antibodies), and KAI1 are metastasis-related factors in cervical cancer. Overexpression of survivin (show BIRC5 Antibodies) and Bcl-2 (show BCL2 Antibodies), and low expression of KAI1 promotes cervical cancer progress and metastasis.

  2. KAI1 was able to suppress melanoma angiogenesis by downregulating IL-6 and VEGF expression.

  3. Loss of both KAI1 and p27 (show PAK2 Antibodies) defines a subgroup of primary melanoma patients with poor prognosis.

  4. The expression of KAI1/CD82, CD44 (show CD44 Antibodies), MMP7 (show MMP7 Antibodies) and beta-catenin (show CTNNB1 Antibodies) is related to tumor metastasis and prognosis in colorectal carcinoma.

  5. Serum-free media and hypoxia protected the MiaPaCa-2 cells from a KAI1-induced apoptosis and proliferation inhibition via autophagy induction.

  6. High KAI1 expression is associated with epithelial-mesenchymal transition in non-small cell lung cancer.

  7. CD82 regulated BCL2L12 (show BCL2L12 Antibodies) expression via STAT5A (show STAT5A Antibodies) and AKT (show AKT1 Antibodies) signaling and stimulated proliferation and engrafting of leukemia cells.

  8. CD82 enhanced the expression of miR (show MLXIP Antibodies)-203 and directly downregulated FZD2 (show FZD2 Antibodies) expression, suppressing cancer metastasis/cell migration by inhibiting the Wnt (show WNT2 Antibodies) signaling pathway.

  9. blockade of CD82 in leukemia cells lowered EZH2 (show EZH2 Antibodies) expression via activation of p38 MAPK (show MAPK14 Antibodies) signaling.

  10. KAI1-splice does not only counteract the tumor-suppressive actions of KAI1, but - beyond that - promotes alphavbeta3-mediated biological functions in favor of tumor progression and metastasis.

CD82 Antigen Profile

Antigen Summary

This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.

Alternative names and synonyms associated with CD82

  • CD82 antigen (Cd82) antibody
  • CD82 molecule (CD82) antibody
  • Cd82 molecule (Cd82) antibody
  • 4F9 antibody
  • AA682076 antibody
  • AL023070 antibody
  • C33 antibody
  • GR15 antibody
  • IA4 antibody
  • KAI1 antibody
  • R2 antibody
  • SAR2 antibody
  • ST6 antibody
  • TSPAN27 antibody

Protein level used designations for anti-CD82 Molecule (CD82) Antibodies

C33 antigen , inducible membrane protein R2 , kangai 1 (suppression of tumorigenicity 6, prostate) , metastasis suppressor Kangai-1 homolog , CD82 antigen , kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , metastasis suppressor Kangai-1 , tetraspanin-27 , tspan-27 , CD82 antigen (R2 leukocyte antigen antigen detected by monoclonal and antibody IA4)) , CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , Kangai 1 (suppression of tumerigenicity 6 prostate) CD82 antigen , Kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , kangai 1 (suppression of tumorigenicity 6), prostate

12521 Mus musculus
3732 Homo sapiens
83628 Rattus norvegicus
Selected quality suppliers for anti-CD82 (CD82) Antibodies
Did you look for something else?